|
"CorePROFIT has successfully and repeatedly demonstrated that its solutions deliver a significant ROI. By using CorePROFIT's industry-leading tools, financial institutions will gain a much deeper level of business intelligence that will be of great value to maximizing profitability."
Glen Bressner, Partner, MAVF
Mid-Atlantic Venture Funds (MAVF) is the sole institutional investor in CorePROFIT Solutions.
 Mid-Atlantic Venture Funds is a leading investor in technology companies based in the Mid-Atlantic states. Since its founding in 1985, Mid-Atlantic Venture Funds has invested in over 85 companies out of four partnerships. Glen Bressner has been a partner with Mid-Atlantic Venture Funds since its founding and has led its investments in IQE plc (LSE), Innovative Solutions & Support (Nasdaq: ISSC), Ravisent Technologies (Nasdaq: RVST), Access Health (Nasdaq: ACCS), AnyTime Access (acquired by Digital Insight), UltraCision (acquired by Johnson & Johnson), MicroE Systems (acquired by GSIG Group) and CareGain (acquired by Fiserv).
Glen Bressner was Chairman of the Greater Philadelphia Venture Group during 1996-1997.
For more information, please contact Glen Bressner at glen@mavf.com.
|
|
